<DOC>
	<DOCNO>NCT00868816</DOCNO>
	<brief_summary>The purpose study investigate oxaliplatie base adjuvant method ( 8 cycle 12 cycle ) good patient receive curative colorectal cancer resection .</brief_summary>
	<brief_title>Oxaliplatine Based Adjuvant Chemotherapy Stage II/III Colorectal Cancer : 8 Cycles Versus 12 Cycles</brief_title>
	<detailed_description>We administer 5-FU , lv Oxaliplatin adjuvant chemotherapy ( 3 week per cycle ) patient Stage II Stage III colorectal cancer . The study endpoints disease-free survival , overall survival , liver metastasis-free survival evaluate intent-to-treat analysis .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<criteria>age &lt; 75 year histologically proven adenocarcinoma colon rectum severe major organ dysfunction WHO performance status 0 1 Stage II ( T34 , N0 , M0 ) Stage III ( T04 , N12 , M0 ) disease ( accord 1997 revision International Union Against Cancer TNM stag system ) age &gt; = 75 severe major organ dysfunction WHO performance status &gt; 1 Stage I Stage IV</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2009</verification_date>
	<keyword>oxaliplatine</keyword>
	<keyword>colorectal cancer</keyword>
	<keyword>chemotherapy</keyword>
</DOC>